These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24158990)

  • 1. Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes.
    Siddiqi FS; Advani A
    Diabetes; 2013 Nov; 62(11):3647-55. PubMed ID: 24158990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
    Fu J; Lee K; Chuang PY; Liu Z; He JC
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
    Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D
    J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes.
    Yoshibayashi M; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Osawa N; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Asanuma K; Maegawa H; Araki SI
    Biochem Biophys Res Commun; 2020 Apr; 525(2):319-325. PubMed ID: 32089264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
    Satchell SC; Tooke JE
    Diabetologia; 2008 May; 51(5):714-25. PubMed ID: 18347777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular podocytes in diabetic renal disease.
    Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
    Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.
    Oltean S; Qiu Y; Ferguson JK; Stevens M; Neal C; Russell A; Kaura A; Arkill KP; Harris K; Symonds C; Lacey K; Wijeyaratne L; Gammons M; Wylie E; Hulse RP; Alsop C; Cope G; Damodaran G; Betteridge KB; Ramnath R; Satchell SC; Foster RR; Ballmer-Hofer K; Donaldson LF; Barratt J; Baelde HJ; Harper SJ; Bates DO; Salmon AH
    J Am Soc Nephrol; 2015 Aug; 26(8):1889-904. PubMed ID: 25542969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.
    Weil EJ; Lemley KV; Mason CC; Yee B; Jones LI; Blouch K; Lovato T; Richardson M; Myers BD; Nelson RG
    Kidney Int; 2012 Nov; 82(9):1010-7. PubMed ID: 22718189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. eNOS deficiency predisposes podocytes to injury in diabetes.
    Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
    J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelium in diabetic nephropathy.
    Advani A; Gilbert RE
    Semin Nephrol; 2012 Mar; 32(2):199-207. PubMed ID: 22617769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with atorvastatin versus rosuvastatin reduces urinary podocytes, podocyte-associated molecules, and proximal tubule dysfunction biomarkers in patients with type 2 diabetes mellitus: a pilot study.
    Vlad A; Vlad M; Petrica L; Ursoniu S; Gadalean F; Popescu R; Vlad D; Dumitrascu V; Gluhovschi G; Gluhovschi C; Velciov S; Bob F; Matusz P; Secara A; Simulescu A; Jianu DC
    Ren Fail; 2017 Nov; 39(1):112-119. PubMed ID: 27841047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Kidney Disease, Endothelial Damage, and Podocyte-Endothelial Crosstalk.
    Gil CL; Hooker E; Larrivée B
    Kidney Med; 2021; 3(1):105-115. PubMed ID: 33604542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.
    Persson F; Rossing P; Hovind P; Stehouwer CD; Schalkwijk CG; Tarnow L; Parving HH
    Scand J Clin Lab Invest; 2008; 68(8):731-8. PubMed ID: 18609080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
    Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
    FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability.
    Swärd P; Rippe B
    Acta Physiol (Oxf); 2012 Mar; 204(3):294-307. PubMed ID: 21812939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
    Jung E; Kim J; Ho Kim S; Kim S; Cho MH
    Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary podocyte mRNAs precede microalbuminuria as a progression risk marker in human type 2 diabetic nephropathy.
    Fukuda A; Minakawa A; Kikuchi M; Sato Y; Nagatomo M; Nakamura S; Mizoguchi T; Fukunaga N; Shibata H; Naik AS; Wiggins RC; Fujimoto S
    Sci Rep; 2020 Oct; 10(1):18209. PubMed ID: 33097787
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.